| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Miller Stephen L | Chief Operating Officer | C/O MEDLINE INC., 3 LAKES DRIVE, NORTHFIELD | /s/ Nicole Fritz, Attorney-in-Fact | 06 Mar 2026 | 0002060964 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MDLN | Class A Common Stock | Award | +25,788 | $0.000000* | 25,788 | 05 Mar 2026 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MDLN | Incentive Units of Medline Holdings, LP | Award | +692,765 | 692,765 | 16 Dec 2025 | Class A Common Stock | 692,765 | $14.58 | See Footnote | F2, F3, F4, F5, F6 | |||
| transaction | MDLN | Incentive Units of Medline Holdings, LP | Award | +106,377 | 106,377 | 16 Dec 2025 | Class A Common Stock | 106,377 | $15.23 | See Footnote | F2, F3, F4, F5, F7 | |||
| transaction | MDLN | Incentive Units of Medline Holdings, LP | Award | +476,031 | 476,031 | 16 Dec 2025 | Class A Common Stock | 476,031 | $19.01 | See Footnote | F2, F3, F4, F5, F8 | |||
| transaction | MDLN | Incentive Units of Medline Holdings, LP | Award | +272,725 | 272,725 | 16 Dec 2025 | Class A Common Stock | 272,725 | $27.68 | See Footnote | F2, F3, F4, F5, F9 |
| Id | Content |
|---|---|
| F1 | Represents a grant of restricted stock units, of which 25% vest on June 15, 2026 and the remaining 75% vest in three equal annual installments beginning on March 1, 2027. |
| F2 | Reflect incentive units of Medline Holdings, LP ("Incentive Units"), which are "profit interests" having economic characteristics similar to stock appreciation rights. Vested Incentive Units are convertible, at the holder's election, into a number of common units of Medline Holdings, LP ("Common Units") generally equal to (a) the product of the number of vested Incentive Units to be converted with a given per unit participation threshold and then-current difference between the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of the Issuer's Class A common stock ("Class A Common Stock")) and the per unit participation threshold of such vested Incentive Units divided by (b) the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock), subject to certain adjustments. |
| F3 | (Continued from Footnote 2 above) Common Units are exchangeable on a one-for-one basis for shares of Class A Common Stock pursuant to the terms of an exchange agreement, dated as of December 16, 2025. These Incentive Units have no expiration date. Such Incentive Units are held indirectly through Medline Management Aggregator LLC. |
| F4 | These securities were acquired in connection with the reclassification of the interests of Medline Holdings, LP prior to the Issuer's initial public offering (as more fully described in the Registration Statement on Form S-1). These securities were previously reported on the Reporting Person's Form 3 filed on December 17, 2025. |
| F5 | These securities are held by a trust, of which the Reporting Person is a trustee. |
| F6 | 60% of these Incentive Units have vested, and the remaining 40% vest in two equal annual installments beginning on July 1, 2026. |
| F7 | 40% of these Incentive Units have vested, and the remaining 60% vest in three equal annual installments beginning on April 1, 2026. |
| F8 | 20% of these Incentive Units have vested, and the remaining 80% vest in four equal annual installments beginning on March 29, 2026. |
| F9 | These Incentive Units vest in five equal annual installments beginning on March 28, 2026. |